PQE Group at Meet the Champions Event by Italy Post and Corriere della Sera

PQE starring at “Meet the Champions” event by Italy Post & “L’Economia”

PQE Group was the special guest for “Meet the Champions” event. PQE Group, selected among the excellent companies in Italy, told about its history last May 17 in Prato, through the words of the COO Claudio Puglisi on the occasion of the “Meet the Champions” event organized by Italy Post in collaboration with “L’Economia” of […]

FDA temporarily retreating on impurities for market shortage

FDA temporarily raising tolerance on impurities due to market shortage

FDA has issued setting temporary rules on a probable cancer-causing impurity formerly regulated. To avoid market shortage of Losartan, drugmakers will be able to make losartan with an impurity percentage above its prescribed level for six months while the supply of clean drugs is ramped up. A calculated risk, to preserve blood pressure drugs availability […]

PQE Opens new office in Hyderabad, Telangana (India).

New office opened in Hyderabad, India.

PQE Group is glad to announce the opening of the new office in the city of Hyderabad (Telangana), India. Grand opening for the second office in India. The grand opening ceremony took place on April 16th 2019, in the presence of PQE Group management representatives: our C.E.O. Gilda D’Incerti, the C.O.O. Claudio Puglisi, PQE India […]

Future of Blockchain in Healthcare

The future of blockchain in healthcare

Blockchain is an increasingly widespread technology that is approaching a stage of maturity that could see an explosion of its use also in the health sector. The point of the situation has been published in “Blockchain in Healthcare Today (BHTY)”, which identifies the ten main trends of this evolution. Consolidation of startups and user education […]

PQE achieves Italian TOP 500

On the occasion of the second edition of “Italy generates future”, an event organized at the Palazzo Mezzanotte, was published by L’Economia, the financial weekly magazine of “Il Corriere della Sera”, the ranking of the 500 Italian companies that have distinguished themselves in 2017 for their profitability. Among these also PQE Group, the Tuscan consulting […]

OIL is a medicine for FDA

Olive oil is a medicine according to FDA

Yes it is! Recently the U.S. Food and Drug Administration (FDA) has determined that there is credible evidence to support a qualified health claim that consuming oleic acid in edible oils, such as olive oil, sunflower oil, or canola oil, may reduce the risk of coronary heart disease. For this reason FDA decided to exercise […]

Claudio Puglisi Elected PDA Italy Chapter Liaison and External Relationship board member

Claudio Puglisi chosen for PDA Executive Committee

PDA Italy Chapter has chosen the new Chief Operating Officer of PQE Group, Claudio Puglisi, as a member of the executive committee for the role of Chapter Liaison and External Relationship. Claudio Puglisi joined the PDA in 1998 as a member and has distinguished himself over the years thanks to his participation in International conferences […]

EMA 2025 Regulatory Strategy Shaping Future Public consultation human stakeholders workshop

EMA 2025 Regulatory Strategy

European Medicines Agency (EMA), has published its draft of ‘Regulatory Science to 2025’ strategy for a six-month public consultation, following the workshop organized last October. This “Reflection Paper” is a proposed plan for advancing the Agency’s engagement with regulatory science over the next five to ten years, covering both human and veterinary medicines. The strategy will […]